Evidence map›Paper›PMID 31505471›Full record

ArticleMethods and applications in fluorescence2019

Simultaneous intraluminal imaging of tissue autofluorescence and eGFP-labeled cells in engineered vascular grafts inside a bioreactor.

Cai Li, Alba Alfonso-Garcia, James McMasters, Julien Bec, Brent Weyers, Lauren Uyesaka, Leigh Griffiths, Alyssa Panitch, Laura Marcu

Abstract read
In one paragraph

Article in Methods and applications in fluorescence, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Cai LiDepartment of Material Science and Engineering, University of California, Davis, United States of America.ORCID 0000-0002-3425-125X
Alba Alfonso-GarciaDepartment of Biomedical Engineering, University of California, Davis, United States of America.
James McMastersDepartment of Biomedical Engineering, University of California, Davis, United States of America.
Julien BecDepartment of Biomedical Engineering, University of California, Davis, United States of America.
Brent WeyersDepartment of Biomedical Engineering, University of California, Davis, United States of America.
Lauren UyesakaDepartment of Biomedical Engineering, University of California, Davis, United States of America.
Leigh GriffithsDepartment of Cardiovascular Diseases, Mayo Clinic, Rochester, United States of America.
Alyssa PanitchDepartment of Biomedical Engineering, University of California, Davis, United States of America.
Laura MarcuDepartment of Biomedical Engineering, University of California, Davis, United States of America.

Funding

Bimodal platform for nondestructive analysis of engineered vascular biomaterialsR01HL121068 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI GRIFFITHS, LEIGH GARETH, MARCU, LAURA · 2015 to 2018
$1.5M
A fiber-coupled multimodal imaging platform for in vitro assessment of engineering tissueR03EB025565 · NIBIB · UNIVERSITY OF CALIFORNIA AT DAVIS · PI MARCU, LAURA · 2017 to 2018
$157k
NHLBI NIH HHS R01 HL121068NIBIB NIH HHS R03 EB025565
6 · The paper itself

Abstract

The growing demand for tissue engineered vascular grafts (TEVG) motivates the development of optimized fabrication and monitoring procedures. Bioreactors which provide physiologically-relevant conditions are important for improving holistic TEVG properties and performance. Herein we describe a fiber-based intraluminal imaging system that allows for in situ assessment of vascular materials and re-cellularization processes inside a bioreactor by simultaneous and co-registered measurements of endogenous fluorescence lifetime and exogenous marker fluorescence intensity. The lumen of 6 vascular grafts (∼4 mm diameter) were scanned by reciprocally rotating a 41° angle polished multimode optical fiber inside a protective glass tube with outer diameter of 3 mm. Tubular bovine pericardium constructs were recellularized using enhanced Green Fluorescent Protein (eGFP) transfected cells in a custom bioreactor. The imaging system has resolved consistently the cellular autofluorescence from that of tissue matrix in situ based on the lifetime fluorescence properties of endogenous molecular species. The location of the re-cellularized area was validated by the eGFP emission. Current results demonstrate the potential of this system as a valuable tool in tissue engineering for in situ studies of cell-tissue interactions in cylindrical or other 3-dimensional structures.

Indexed as

BioreactorsBlood Vessel ProsthesisGreen Fluorescent ProteinsHumansMesenchymal Stem CellsOptical FibersOptical ImagingPhantoms, ImagingTime Factorsenhanced green fluorescent proteinGreen Fluorescent Proteins

Identifiers

PMID31505471
PMCPMC7539617

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.